Monograph
R03CC03 - Terbutaline |
Not porphyrinogenic |
NP |
Rationale
Rather low dose In large part not metabolised. No indication for CYP-interaction. One reference: authorised.
Chemical description
Adrenergic bronchodilator for systemic treatment (solution for injection or infusion 0,5 mg/mL) used in bronchospasm of various origin. Metabolized by sulfation, about 60% excreted in urine in unchanged form. French list: authorized
IPNet drug reports
Uneventful use reported in 5 patients with acute porphyria.
Similar drugs
Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia).
Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway).
What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names
are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
United Kingdom
Denmark
Norway
Iceland
Finland© NAPOS 2024